首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   62568篇
  免费   6001篇
  国内免费   2313篇
耳鼻咽喉   560篇
儿科学   1288篇
妇产科学   1213篇
基础医学   7600篇
口腔科学   1222篇
临床医学   7538篇
内科学   11230篇
皮肤病学   1132篇
神经病学   3727篇
特种医学   2142篇
外国民族医学   23篇
外科学   7499篇
综合类   5949篇
现状与发展   5篇
一般理论   35篇
预防医学   4180篇
眼科学   2251篇
药学   5650篇
  46篇
中国医学   2489篇
肿瘤学   5103篇
  2024年   189篇
  2023年   920篇
  2022年   2041篇
  2021年   2754篇
  2020年   2011篇
  2019年   1920篇
  2018年   2112篇
  2017年   1845篇
  2016年   1880篇
  2015年   2511篇
  2014年   3039篇
  2013年   3228篇
  2012年   4343篇
  2011年   4689篇
  2010年   2874篇
  2009年   2506篇
  2008年   3333篇
  2007年   3299篇
  2006年   3221篇
  2005年   3092篇
  2004年   2432篇
  2003年   2275篇
  2002年   2002篇
  2001年   1551篇
  2000年   1490篇
  1999年   1346篇
  1998年   618篇
  1997年   539篇
  1996年   415篇
  1995年   376篇
  1994年   340篇
  1993年   283篇
  1992年   564篇
  1991年   534篇
  1990年   526篇
  1989年   475篇
  1988年   442篇
  1987年   429篇
  1986年   376篇
  1985年   309篇
  1984年   227篇
  1983年   167篇
  1982年   100篇
  1981年   102篇
  1980年   103篇
  1979年   168篇
  1978年   98篇
  1977年   83篇
  1976年   84篇
  1975年   90篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
61.
不同临床和病理分型对肝门部胆管癌切除术预后的影响   总被引:2,自引:0,他引:2  
目的 研究临床和病理分型与肝门部胆管癌切除术疗效的关系。方法总结1993年至2004年在解放军总医院肝胆外科手术切除的肝门部胆管癌198例病例资料。结果临床分型Ⅰ型34例,Ⅱ型60例,Ⅲa型27例,Ⅲb型33例,Ⅳ型19例,Ⅴa型6例。Ⅴb型19例。病理高分化腺癌35例,中分化腺癌52例,低分化腺癌54例,三者的中位生存期分别为29.5、11、5.5个月;病理切缘阴性者与切缘阳性者生存率有显著性差异(P 〈0.05)。手术并发症出现率41.4%,围手术期死亡1例。结论肝门部胆管癌根据临床分型进行相应的手术治疗;病理切缘阴性是影响预后的主要因素之一;围手术期正确处理,是减少手术并发症,提高患者生活质量和延长生存期的关键。  相似文献   
62.
OBJECTIVE: The aim of this study was to determine whether the survival of patients with untreated synchronous liver metastases after resection of a colorectal cancer was associated with any features of the primary tumour. METHODS: Information for 398 consecutive patients with unresected liver metastases in the period 1971-2001 was examined by multivariate survival analysis. RESULTS: Of 19 clinical and pathological variables considered, survival was independently associated only with residual tumour in a line of resection (hazard ratio (HR) 1.95), venous invasion (HR 1.87), right colonic tumour (HR 1.68), lymph node metastasis (HR 1.54), and extra-hepatic metastasis (HR 1.16); 8.3% of patients had none of these adverse features. Their 2-year overall survival rate was 39.2%, compared with only 16.5% (P < 0.001) in those with one or more adverse features. CONCLUSIONS: These findings may assist in selecting patients most likely to benefit from treatment of hepatic metastases and in counselling patients and their relatives.  相似文献   
63.
The appearance of an acute effusion in a well-pneumatized temporal bone directs attention to the nasopharynx and skull base. Two patients are described in whom dehiscence of the temporomandibular joint allowed herniation of the contents of the joint posteromedically, where they obstructed the middle ear entrance of the eustachian tube, the protympanum. This is, to the authors' knowledge, a previously unreported cause of an acute middle ear and mastoid effusion.  相似文献   
64.
目的:探讨细胞活素肿瘤坏死因子-α(TNF-α)、SNAP(S-Nitroso-Nacetyl-penicillamine)对胰腺癌细胞产生血管内皮生长因子A、C(VEGF-A、C)的调节.方法:用Northern杂交和Western杂交法分析6种人胰腺癌细胞株中VEGF-A、C基因和蛋白的表达;以TNF-α或SNAP刺激其中两个细胞株后用逆转录-聚合酶链式反应技术(RT-PCR)分析其VEGF-A、C基因的表达.结果:Northern杂交法显示这6种胰腺癌细胞株均有4.1kb VEGF-A基因和2.4kb VEGF-C基因的表达;Western杂交法显示它们均有分子量为43kD的VEGF-A蛋白质和分子量为55kD的VEGF-C蛋白质的表达.RT-PCR分析法显示:TNF-α使细胞株COLO-357产生VEGF-A、VEGF-C mRNA分别减少约1~2.5倍、1~2倍,使细胞株CAPAN-1产生VEGF-A、VEGF-C mRNA分别减少约1倍、1.6~2.5倍;而SNAP刺激细胞株COLO-357产生VEGF-A mRNA增加约5倍,刺激细胞株CAPAN-1产生VEGF-A mRNA增加约4倍,但对这两种细胞株产生VEGF-C mRNA均无明显刺激作用.结论:细胞活素TNF-α和低氧通过调节血管内皮生长因子A、C的表达而影响胰腺癌细胞的生物学特性,抑制癌细胞的增殖,促进其凋亡、死亡或进展、恶化.  相似文献   
65.
Although many monoclonal antibodies have been made in human colon cancer, none of them are from the Chinese species. Recently, a colon cancer cell line CC-M2 established from a Chinese patient has been completely characterized and used as immunogen to produce monoclonal antibodies. Monoclonal antibodies were produced by standard hybridoma technique. The fusion rate was 95.8%. An isotype IgG1 of high proliferation named as Sam-2 was used in this study. The titers were measured around 10(4). Further studies on MoAb Sam-2 through indirect immunofluorescent and immunoperoxidase tests revealed its good specificity and sensitivity in colorectal cancer tissue. In CEA study, the result indicated that Sam-2 may react on a non-CEA related antigen. For further clinical application, the antigen was identified as a glycoprotein by chemical resistant test. In preliminary studies using sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblotting techniques, Sam-2 could recognize two closed antigens or a dimer antigen with molecular weight 25.2 and 27 Kd respectively.  相似文献   
66.
The clinical presentation and the biochemical and molecular genetic findings are described in a 13 year old Chinese boy with MELAS (mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes). The diagnosis was initially suspected because of the characteristic clinical features and the strong family history of convulsions. Using polymerase chain reaction—restriction enzyme analysis, the heteroplasmic nt3243 A→G mutation in mtDNA of peripheral blood leucocytes and a muscle sample was demonstrated. The oligosymptomatic relatives were then screened by this method and the degree of heteroplasmy was analysed. This appears to be the first report of a MELAS family in Hong Kong with this described mutation. Molecular genetic techniques are advantageous in the diagnosis of MELAS.  相似文献   
67.
应用双光子及单光子吸收测定技术,检测了92名出生3d内的新生儿骨矿质含量,其中巨大儿30名,正常体重儿32名,低出生体重儿30名,其孕龄分别是40.1±0.7、39.1±1.5和37.4±1.2孕周。结果表明,巨大儿、正常体重儿、低出生体重儿的全身骨矿质含量分别是101.6±28.8、85.2±19.8、59.9±27.2g/cm2,巨大儿骨矿质含量最高,正常体重儿次之,低出生体重儿最低,差异有显著性(P<0.01)。颅骨、肱骨、股骨的骨矿质含量与全身的骨矿质含量有高度的相关性,相关系数分别是0.943、0.879和0.745(P<0.01)。全身的骨矿质含量与出生体重、孕龄及头围有高度相关性,相关系数分别是0.755、0.596和0.556(P<0.01)。提示颅骨、肱骨及股骨的任一部位均可代表全身的骨矿质含量,肱骨是确定全身骨矿质含量较好的部位,新生儿骨矿质含量受出生体重、孕龄及头围的影响较大。  相似文献   
68.
Immunopathologic study of Vogt-Koyanagi-Harada syndrome   总被引:9,自引:0,他引:9  
We studied an enucleated eye from a patient with a 30-year history of Vogt-Koyanagi-Harada syndrome using both conventional and immunohistochemical techniques. Clinically, the eye was in the end stage of Vogt-Koyanagi-Harada syndrome, and was characterized by the absence of inflammation, large areas of chorioretinal scarring, and pigmentary changes. Histopathologic examination showed marked retinal gliosis, extensive chorioretinal adhesion and scar formation, migration of pigment into the retina, and severe retinal pigment epithelial changes. However, foci of mild to moderate nongranulomatous inflammation of the uvea were observed. These foci contained infiltrating cells that were mainly T lymphocytes with B lymphocyte aggregates at the center. Scattered macrophages were also noted in the uvea and retina. These findings suggest that both the cell-mediated and humoral immune arms may play roles in the pathogenesis of Vogt-Koyanagi-Harada syndrome.  相似文献   
69.
竹荪深层发酵菌丝体对小鼠免疫功能的影响及其抗肿瘤作用   总被引:12,自引:0,他引:12  
过对食药用真菌──竹荪深层发酵菌丝体提取液对小鼠免疫功能及S-180肿瘤细胞的作用观察,表明其发酵菌丝体可明显提高小鼠腹腔巨噬细胞的吞噬功能(P<0.01),并显著增加免疫器官的重量(P<0.05);对小鼠S-180肿瘤的抑瘤率为40.63%。  相似文献   
70.
Studies on the effectiveness of pain management have uniformly concluded that health care providers underestimate or undertreat pain. In the emergency department (ED) in which this study was conducted, physicians receive formal didactic and bedside teaching on pain recognition and management in order to heighten the awareness of patient's need for pain control. The purpose of this study was to determine if this outpatient pain management of patients with acute, painful conditions is better than that reported in the medical literature. In this prospective study, 110 adult patients who had an acute, painful diagnosis were telephoned 48 hours after discharge from the ED and asked if they felt their pain at home was well controlled. Patient satisfaction with pain control was higher (91%) than that reported in the medical literature. Also, pain medication was provided more frequently by this study's ED (95%). Education on pain awareness and treatment is a way to improve pain management.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号